LIFECORE BIOMEDICAL, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
LIFECORE BIOMEDICAL, INC. (LFCR) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $0 for the 9-month period ending 2016-02-28, per its 10-Q filed 2016-03-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2016-03-30
- LIFECORE BIOMEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-02-28 was $0.00.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2016-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $0.00 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $0.00 10-Q · filed 2016-01-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |